Let Activefol.io Invest in ABMD on Your Behalf.
- Active Investing
- Personalized Strategy
- Low Monthly Fees
Course of Action
Sentiment (10 days)
- Strong Buy
- Strong Sell
DAILY PRICE CHANGE VS SENTIMENT
What is Systematic Investing?
Activefol.io is an advanced automated Portfolio Manager designed to provides investors with a state of the art automated investment system to invest in the S&P 500®. Its technology is designed to screen, monitor and invest in elite stocks like "ABIOMED INC. (ABMD)". It's Artificial Intelligence augments your potential for profit while eliminating most of the work traditionally involved in stock investing.
What is Activefol.io good for?
If you are interested in systematic, active investing, Activefol.io can be a great alternative to passive index funds and ETFs. Activefol.io uses Artificial Intelligence concepts to screen, monitor and invest in elite stocks. Used in a tax-deferred account such as IRAs and Roth IRAs, it invests systematically using carefully instrumented strategies. Using Activefol.io is like having a professional Portfolio Manager working for you. You turn it on and it starts working on your behalf.
Activefol.io actively trades the S&P 500®, day-in, and day-out, while you attend more important life events. Because of the systematic nature of Activefol.io, your account has the potential to grow at a faster rate than if you were to use a passive investment product such as an index fund or ETF. Systematic active trading using Artificial Intelligence holds the potential to grow your account faster.
Using Activefol.io is Easy
To connect Activefol.io to your account you will need to open an account with one of our Broker / Dealer partners in the United States. Our Partners offer very competitive services and flawless execution.
There are clear benefits associated with using Activefol.io to help you reach your financial goals. Activefol.io simplifies stock investing down to a few easy steps. It systematically invests for you, using your personalized strategy.
Using Activefol.io is like having a professional Portfolio Manager working for you to help you reach your financial goals.
Activefol.io actively invests which is different from passive investing. Our automated solution is on the lookout, working to maximize your potential every minute of a business day. It 'trades on the news' taking advantage of changes.
Activefol.io is one of the first platforms to take advantage of Government grade listening technology to monitor and classify securities.
Try Activefol.io today!
You can test Activefol.io in simulation mode, risk free, Stock Circles today.
Get started now - and see where active automated trading can take you.
Disclaimer: Past performance may not be indicative of future results. Therefore, you should assume that the future performance of any specific investment and systematic investment strategies will be profitable. Activefol.io, like other investment methods, rely on favorable market conditions to provide positive outcomes.
ABIOMED INC. (ABMD) News
CENTRAL TRUST Co Acquires 898 Shares of ABIOMED, Inc. (NASDAQ:ABMD)
Aug 2nd, 2018 - CENTRAL TRUST Co lifted its stake in ABIOMED, Inc. (NASDAQ:ABMD) by 35.5% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,425 shares of the medical equipment provider’s stock after purchasing an additional 898 shares during the period. CENTRAL TRUST Co’s holdings in ABIOMED were worth $1,401,000 at the end of the most recent quarter.
Several other institutional investors also recently modified their holdings of ABMD. Winslow Capital Management LLC bought a new stake in ABIOMED in the 1st quarter valued at $228,454,000. Franklin Resources Inc. lifted its position in ABIOMED by 90.4% during the 1st quarter. Franklin Resources Inc. now owns 625,987 shares of the medical equipment provider’s stock worth $182,158,000 after buying an additional 297,270 shares in the last quarter. BlackRock Inc. lifted its position in ABIOMED by 4.9% during the 1st quarter. BlackRock Inc. now owns 3,697,535 shares of the medical equipment provider’s stock worth $1,075,946,000 after buying an additional 172,329 shares in the last quarter. JPMorgan Chase & Co. increased its stake in shares of ABIOMED by 239.3% during the 1st quarter. JPMorgan Chase & Co. now owns 211,201 shares of the medical equipment provider’s stock worth $61,458,000 after purchasing an additional 148,950 shares during the last quarter. Finally, Rockefeller Capital Management L.P. acquired a new position in shares of ABIOMED during the 1st quarter worth about $40,307,000. 86.89% of the stock is owned by institutional investors and hedge funds.Get Started today! - Risk Free